BMC Medical Co. Ltd. A - Asset Resilience Ratio
BMC Medical Co. Ltd. A (301367) has an Asset Resilience Ratio of 47.31% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See how financially flexible is BMC Medical Co. Ltd. A to measure the company's free cash flow as a share of total liabilities.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2020–2025)
This chart shows how BMC Medical Co. Ltd. A's Asset Resilience Ratio has changed over time. See 301367 net asset quality index to measure how much of total assets are equity-financed.
Liquid Assets Composition Over Time
This chart breaks down BMC Medical Co. Ltd. A's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see how much is BMC Medical Co. Ltd. A worth.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 0% |
| Short-term Investments | CN¥1.60 Billion | 47.31% |
| Total Liquid Assets | CN¥1.60 Billion | 47.31% |
Asset Resilience Insights
- Very High Liquidity: BMC Medical Co. Ltd. A maintains exceptional liquid asset reserves at 47.31% of total assets.
- This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
- The company has significant short-term investments, indicating active treasury management.
BMC Medical Co. Ltd. A Industry Peers by Asset Resilience Ratio
Compare BMC Medical Co. Ltd. A's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Gan & Lee Pharmaceuticals Co Ltd
SHG:603087 |
Medical Instruments & Supplies | 9.87% |
|
Andon Health Co Ltd
SHE:002432 |
Medical Instruments & Supplies | 18.11% |
|
Pegavision
TW:6491 |
Medical Instruments & Supplies | 17.14% |
|
Tarsons Products Limited
NSE:TARSONS |
Medical Instruments & Supplies | 0.47% |
|
SciVision Biotech Inc
TW:1786 |
Medical Instruments & Supplies | 7.81% |
|
Nyxoah
BR:NYXH |
Medical Instruments & Supplies | 12.40% |
|
I.Ceram SA
PA:ALICR |
Medical Instruments & Supplies | -1.61% |
|
Ansell Ltd
AU:ANN |
Medical Instruments & Supplies | 7.53% |
Annual Asset Resilience Ratio for BMC Medical Co. Ltd. A (2020–2025)
The table below shows the annual Asset Resilience Ratio data for BMC Medical Co. Ltd. A.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 44.76% | CN¥1.52 Billion ≈ $221.73 Million |
CN¥3.38 Billion ≈ $495.33 Million |
-21.97pp |
| 2024-12-31 | 66.74% | CN¥2.29 Billion ≈ $334.47 Million |
CN¥3.42 Billion ≈ $501.16 Million |
+4.64pp |
| 2023-12-31 | 62.10% | CN¥1.81 Billion ≈ $265.22 Million |
CN¥2.92 Billion ≈ $427.07 Million |
-11.70pp |
| 2022-12-31 | 73.80% | CN¥2.16 Billion ≈ $316.08 Million |
CN¥2.93 Billion ≈ $428.28 Million |
+26.50pp |
| 2021-12-31 | 47.30% | CN¥295.00 Million ≈ $43.17 Million |
CN¥623.69 Million ≈ $91.27 Million |
+20.78pp |
| 2020-12-31 | 26.52% | CN¥124.00 Million ≈ $18.15 Million |
CN¥467.64 Million ≈ $68.43 Million |
-- |
About BMC Medical Co. Ltd. A
BMC Medical Co., Ltd. researches, develops, manufactures, and supplies medical equipment and consumable in the field of respiratory health in China. It offers sleep-disordered breathing (SDB) diagnostic devices, non-invasive ventilators, high-flow nasal cannula oxygen therapy devices, oxygen concentrator, and respiratory consumables, such as various types of masks, breathing tubes, etc., as well … Read more